Application 210526
- Type
- NDA
- Sponsor
- TRIS PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DYANAVEL XR | AMPHETAMINE | TABLET, EXTENDED RELEASE;ORAL | 5MG | No | No |
| 002 | DYANAVEL XR | AMPHETAMINE | TABLET, EXTENDED RELEASE; ORAL | 10MG | No | No |
| 003 | DYANAVEL XR | AMPHETAMINE | TABLET, EXTENDED RELEASE;ORAL | 15MG | No | No |
| 004 | DYANAVEL XR | AMPHETAMINE | TABLET, EXTENDED RELEASE; ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N210526-001 | DYANAVEL XR 5 | AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | |
| N210526-002 | DYANAVEL XR 10 | AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | |
| N210526-003 | DYANAVEL XR 15 | AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | |
| N210526-004 | DYANAVEL XR 20 | AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N210526-001 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-001 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-001 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-001 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 |
| N210526-001 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | |
| N210526-002 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-002 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-002 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-002 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 |
| N210526-002 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | |
| N210526-003 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-003 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-003 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-003 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 |
| N210526-003 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | |
| N210526-004 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-004 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-004 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | |
| N210526-004 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 |
| N210526-004 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210526-001 | DYANAVEL XR 5 | 4MG;EQ 1MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210526-002 | DYANAVEL XR 10 | 8MG;EQ 2MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210526-003 | DYANAVEL XR 15 | 12MG;EQ 3MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2021-11-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210526-004 | DYANAVEL XR 20 | 16MG;EQ 4MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2021-11-04 | d06236e962d9… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-001 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-002 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-003 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N210526-004 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-001 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-002 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-003 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | 8337890 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | 8747902 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | 9675704 | 2027-03-15 | Drug product | 2021-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | 11590081 | 2038-09-24 | U-3538 | Drug product | 2023-03-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210526-004 | 12458592 | 2040-02-11 | U-3538 | 2025-11-14 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dyanavel XR | AMPHETAMINE | NextWave Pharmaceuticals, Inc | ae304b29-0b40-40ec-ad0d-76b742d4a9b9 | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 210526 NDA210526 24478-109 24478-110 24478-108 24478-106 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24478-106 | DYANAVEL XR | amphetamine | NextWave Pharmaceuticals, Inc | NDA | Current |
| 24478-108 | DYANAVEL XR | amphetamine | NextWave Pharmaceuticals, Inc | NDA | Current |
| 24478-109 | DYANAVEL XR | amphetamine | NextWave Pharmaceuticals, Inc | NDA | Current |
| 24478-110 | DYANAVEL XR | amphetamine | NextWave Pharmaceuticals, Inc | NDA | Current |
| 27808-106 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-106 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-106 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-108 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-108 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-108 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-109 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-109 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-109 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-110 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-110 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
| 27808-110 | DYANAVEL XR | amphetamine | Tris Pharma Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83496 | SUPPL | 2025-09-25 |
| 83495 | SUPPL | 2025-09-25 |
| 83452 | SUPPL | 2025-09-25 |
| 75789 | SUPPL | 2023-10-17 |
| 75769 | SUPPL | 2023-10-16 |
| 72352 | SUPPL | 2022-10-17 |
| 71213 | SUPPL | 2022-06-06 |
| 71204 | SUPPL | 2022-06-02 |
| 70567 | ORIG | 2022-03-21 |
| 70380 | SUPPL | 2022-03-02 |
| 70379 | SUPPL | 2022-03-02 |
| 70296 | SUPPL | 2022-02-28 |
| 69271 | ORIG | 2021-11-08 |
| 69270 | ORIG | 2021-11-08 |
| 69269 | ORIG | 2021-11-08 |